Thatcher, N., Dazzi, H., Johnson, R. J., Russell, S., Ghosh, A. K., Moore, M., . . . Craig, R. D. (1989). Recombinant interleukin-2 (rIL-2) given intrasplenically and intravenously for advanced malignant melanoma. A phase I and II study. Nature Publishing Group.
Chicago Style CitationThatcher, N., H. Dazzi, R. J. Johnson, S. Russell, A. K. Ghosh, M. Moore, G. Chadwick, i R. D. Craig. Recombinant Interleukin-2 (rIL-2) Given Intrasplenically and Intravenously for Advanced Malignant Melanoma. A Phase I and II Study. Nature Publishing Group, 1989.
Cita MLAThatcher, N., et al. Recombinant Interleukin-2 (rIL-2) Given Intrasplenically and Intravenously for Advanced Malignant Melanoma. A Phase I and II Study. Nature Publishing Group, 1989.
Atenció: Aquestes cites poden no estar 100% correctes.